Inovio Pharmaceuticals, Inc. Class Action Lawsuit
Company: Inovio Pharmaceuticals, Inc.
Ticker: (NASDAQ) INO
Class Action Period: October 10, 2023 - December 26, 2025
See If You Qualify For Monetary Reward
Join the Inovio Pharmaceuticals, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
October 10, 2023 - December 26, 2025
Allegations
The complaint filed against Inovio Pharmaceuticals, Inc. alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (i) manufacturing for Inovio’s CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit it's lead product candidate, INO-3107 BLA to the FDA by the second half of 2024; (iii) Inovio had insufficient information to justify the INO-3107 BLA’s eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107’s overall regulatory and commercial prospects were overstated; and (v) as a result, defendants’ public statements were materially false and misleading at all relevant times.
Eligibility
To join the lawsuit, you must have experienced a loss on Inovio Pharmaceuticals, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Inovio Pharmaceuticals, Inc. during the relevant time frame, you have until April 7, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against Inovio Pharmaceuticals, Inc. (NASDAQ: INO)?
Investors who purchased shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) during the class period (October 10, 2023 - December 26, 2025) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is April 7, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the Inovio Pharmaceuticals, Inc. lawsuit?
Anyone who bought shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) during October 10, 2023 - December 26, 2025 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the Inovio Pharmaceuticals, Inc. case?
The lead plaintiff deadline for the Inovio Pharmaceuticals, Inc. lawsuit is April 7, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for Inovio Pharmaceuticals, Inc.?
The class period for Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is October 10, 2023 - December 26, 2025, during which investors may have been affected by alleged misconduct.
- Can I still join the Inovio Pharmaceuticals, Inc. lawsuit if I sold my shares?
Yes. Investors who purchased Inovio Pharmaceuticals, Inc. shares during October 10, 2023 - December 26, 2025 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the Inovio Pharmaceuticals, Inc. lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the Inovio Pharmaceuticals, Inc. case may receive a portion of the recovery.
- Do I need to pay to participate in the Inovio Pharmaceuticals, Inc. case?
No, most securities fraud cases involving Inovio Pharmaceuticals, Inc. operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the Inovio Pharmaceuticals, Inc. lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the Inovio Pharmaceuticals, Inc. case on behalf of participants.
- What documents are required for the Inovio Pharmaceuticals, Inc. lawsuit?
To participate in the Inovio Pharmaceuticals, Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for Inovio Pharmaceuticals, Inc.?
After submission, your details for the Inovio Pharmaceuticals, Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the Inovio Pharmaceuticals, Inc. lawsuit?
No, this page provides information about the Inovio Pharmaceuticals, Inc. case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the Inovio Pharmaceuticals, Inc. case?
The lead plaintiff deadline for the Inovio Pharmaceuticals, Inc. lawsuit is April 7, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
Soleno Therapeutics, Inc.
SLNO
Lead Plaintiff Deadline: May 5, 2026
Class Period: March 26, 2025 - November 4, 2025
NuScale Power Corporation
SMR
Lead Plaintiff Deadline: April 20, 2026
Class Period: May 13, 2025 - November 6, 2025